MoneyWorks4Me

Laurus Labs informs about closure of trading window

31 Dec 2022 Evaluate

Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, Laurus Labs has informed that the trading window for dealing in the shares of the Company shall remain closed from January 01, 2023 till 48 hours after the declaration of un-audited financial results for the quarter and nine months ended December 31, 2022. The date of Board Meeting of the Company for consideration and approval of the un-audited financial results for the quarter and nine months ended December 31, 2022 will be intimated later.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..